Literature DB >> 19941835

Aberrant glutamate receptor 5 expression in temporal lobe epilepsy lesions.

Jin-Mei Li1, Yi-Jun Zeng, Fang Peng, Li Li, Tian-Hua Yang, Zhen Hong, Ding Lei, Zhong Chen, Dong Zhou.   

Abstract

Glutamate receptor 5 (GluR5) plays a role as an excitatory regulator of synaptic transmission and plasticity; however, its exact role in the pathological mechanism underlying epilepsy is not fully known. We investigated GluR5 expression in resected brain tissues from humans with temporal lobe epilepsy (TLE) and from a macaque model of Coriaria lactone-induced TLE. GluR5 was upregulated in the hippocampus, but not in the temporal neocortex, of patients with TLE compared to the control group. In contrast, GluR5 expression in the hippocampus of macaques treated with Coriaria lactone was not upregulated compared to the control. In addition, mossy fiber sprouting in the hippocampus of TLE patients was correlated with GluR5 upregulation, whereas mossy fiber sprouting was not observed in the macaque model lacking GluR5 upregulation, suggesting that GluR5 function is mainly associated with mossy fiber sprouting. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941835     DOI: 10.1016/j.brainres.2009.11.024

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

Review 1.  Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.

Authors:  Sharon S McDaniel; Michael Wong
Journal:  Neurosci Lett       Date:  2011-02-24       Impact factor: 3.046

2.  Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Volodymyr I Pidoplichko; Katia Rossetti; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2018-02-21       Impact factor: 4.030

3.  The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology.

Authors:  Taiza H Figueiredo; Felicia Qashu; James P Apland; Vassiliki Aroniadou-Anderjaska; Adriana P Souza; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2010-10-20       Impact factor: 4.030

Review 4.  Structure, Function, and Regulation of the Kainate Receptor.

Authors:  Surbhi Dhingra; Juhi Yadav; Janesh Kumar
Journal:  Subcell Biochem       Date:  2022

5.  Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus.

Authors:  Cheng Huang; Xiao-Sa Chi; Rui Li; Xin Hu; Hai-Xia Xu; Jin-Mei Li; Dong Zhou
Journal:  J Mol Neurosci       Date:  2017-08-30       Impact factor: 3.444

Review 6.  The kainic acid model of temporal lobe epilepsy.

Authors:  Maxime Lévesque; Massimo Avoli
Journal:  Neurosci Biobehav Rev       Date:  2013-10-30       Impact factor: 8.989

7.  Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Marcio De Araujo Furtado; Maria F M Braga
Journal:  Neurotox Res       Date:  2018-04-30       Impact factor: 3.911

Review 8.  Therapeutic potential of kainate receptors.

Authors:  Carlos Matute
Journal:  CNS Neurosci Ther       Date:  2010-12-06       Impact factor: 5.243

9.  A macaque model of mesial temporal lobe epilepsy induced by unilateral intrahippocampal injection of kainic Acid.

Authors:  Ning Chen; Chong Liu; Na Yan; Wei Hu; Jian-guo Zhang; Yan Ge; Fan-gang Meng
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

10.  The Role of Kainate Receptors in the Pathophysiology of Hypoxia-Induced Seizures in the Neonatal Mouse.

Authors:  Denise K Grosenbaugh; Brittany M Ross; Pravin Wagley; Santina A Zanelli
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.